103 related articles for article (PubMed ID: 17277970)
1. Stereological analysis of the poly-(DL-lactide-co-glycolide) submicron sphere prepared by solvent/non-solvent chemical methods and centrifugal processing.
Stevanovic M; Ignjatovic N; Jordovic B; Uskokovic D
J Mater Sci Mater Med; 2007 Jul; 18(7):1339-44. PubMed ID: 17277970
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
Ravi Kumar MN; Bakowsky U; Lehr CM
Biomaterials; 2004 May; 25(10):1771-7. PubMed ID: 14738840
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of poly(D,L-lactide-co-glycolide) nanoparticles containing ascorbic acid.
Stevanović MM; Jordović B; Uskoković DP
J Biomed Biotechnol; 2007; 2007(7):84965. PubMed ID: 18273414
[TBL] [Abstract][Full Text] [Related]
4. Controlling surface nano-structure using flow-limited field-injection electrostatic spraying (FFESS) of poly(D,L-lactide-co-glycolide).
Berkland C; Pack DW; Kim KK
Biomaterials; 2004 Nov; 25(25):5649-58. PubMed ID: 15159081
[TBL] [Abstract][Full Text] [Related]
5. Solvent effects on the microstructure and properties of 75/25 poly(D,L-lactide-co-glycolide) tissue scaffolds.
Sander EA; Alb AM; Nauman EA; Reed WF; Dee KC
J Biomed Mater Res A; 2004 Sep; 70(3):506-13. PubMed ID: 15293325
[TBL] [Abstract][Full Text] [Related]
6. Critical properties of lactide-co-glycolide polymers for the use in microparticle preparation by the aerosol solvent extraction system.
Engwicht A; Girreser U; Müller BW
Int J Pharm; 1999 Aug; 185(1):61-72. PubMed ID: 10425366
[TBL] [Abstract][Full Text] [Related]
7. Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods.
Kawashima Y; Yamamoto H; Takeuchi H; Hino T; Niwa T
Eur J Pharm Biopharm; 1998 Jan; 45(1):41-8. PubMed ID: 9689534
[TBL] [Abstract][Full Text] [Related]
8. Production of microspheres with surface amino groups from blends of Poly(Lactide-co-glycolide) and Poly(epsilon-CBZ-L-lysine) and use for encapsulation.
Zheng J; Hornsby PJ
Biotechnol Prog; 1999; 15(4):763-7. PubMed ID: 10441368
[TBL] [Abstract][Full Text] [Related]
9. Effects of carbon nanotubes (CNTs) on the processing and in-vitro degradation of poly(DL-lactide-co-glycolide)/CNT films.
Armentano I; Dottori M; Puglia D; Kenny JM
J Mater Sci Mater Med; 2008 Jun; 19(6):2377-87. PubMed ID: 18158616
[TBL] [Abstract][Full Text] [Related]
10. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
Dong Y; Feng SS
Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
[TBL] [Abstract][Full Text] [Related]
12. Poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanospheres. Part 1: A multifunctional system for controlled drug delivery.
Vukomanović M; Skapin SD; Jančar B; Maksin T; Ignjatović N; Uskoković V; Uskoković D
Colloids Surf B Biointerfaces; 2011 Feb; 82(2):404-13. PubMed ID: 20951005
[TBL] [Abstract][Full Text] [Related]
13. Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres.
Jung T; Breitenbach A; Kissel T
J Control Release; 2000 Jul; 67(2-3):157-69. PubMed ID: 10825550
[TBL] [Abstract][Full Text] [Related]
14. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
15. Polyethylene glycol as an alternative polymer solvent for nanoparticle preparation.
Ali ME; Lamprecht A
Int J Pharm; 2013 Nov; 456(1):135-42. PubMed ID: 23958752
[TBL] [Abstract][Full Text] [Related]
16. Particle size control of poly(dl-lactide-co-glycolide) nanospheres for sterile applications.
Tsukada Y; Hara K; Bando Y; Huang CC; Kousaka Y; Kawashima Y; Morishita R; Tsujimoto H
Int J Pharm; 2009 Mar; 370(1-2):196-201. PubMed ID: 19100320
[TBL] [Abstract][Full Text] [Related]
17. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method.
Leo E; Pecquet S; Rojas J; Couvreur P; Fattal E
J Microencapsul; 1998; 15(4):421-30. PubMed ID: 9651864
[TBL] [Abstract][Full Text] [Related]
18. Characterization of ciclosporin A loaded poly (D,L lactide-co-glycolide) microspheres using modulated temperature differential scanning calorimetry.
Passerini N; Craig DQ
J Pharm Pharmacol; 2002 Jul; 54(7):913-9. PubMed ID: 12162709
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
[TBL] [Abstract][Full Text] [Related]
20. Influence of additives on the release profile of nifedipine from poly(DL-lactide-co-glycolide) microspheres.
Sansdrap P; Moës AJ
J Microencapsul; 1998; 15(5):545-53. PubMed ID: 9743911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]